Literature DB >> 18443816

Pharmacological and biophysical properties of Ca2+ channels and subtype distributions in human adrenal chromaffin cells.

Alberto Pérez-Alvarez1, Alicia Hernández-Vivanco, María Cano-Abad, Almudena Albillos.   

Abstract

In this study, we explored the pharmacological and biophysical properties of voltage-activated Ca2+ channels in human chromaffin cells using the perforated-patch configuration of the patch-clamp technique. According to their pharmacological sensitivity to Ca2+ channel blockers, cells could be sorted into two groups of similar size showing the predominance of either N- or P/Q-type Ca2+ channels. R-type Ca2+ channels, blocked by 77% with 20 muM Cd2+ and not affected by 50 muM Ni2+, were detected for the first time in human chromaffin cells. Immunocytochemical experiments revealed an even distribution of alpha (1E) Ca2+ channels in these cells. With regard to their biophysical properties, L- and R-type channels were activated at membrane potentials that were 15-20 mV more negative than P/Q- and N-type channels. Activation time constants showed no variation with voltage for the L-type channels, decreased with increasing potentials for the R- and P/Q-type channels, and displayed a bell shape with a maximum at 0 mV for the N-type channels. R-type channels were also the most inactivated channels. We thus show here that human chromaffin cells possess all the Ca2+ channel types described in neurons, L, N, P/Q, and R channels, but the relative contributions of N and P/Q channels differ among cells. Given that N- and P/Q-type Ca2+ channel types can be differentially modulated, these findings suggest the possibility of cell-specific regulation in human chromaffin cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443816     DOI: 10.1007/s00424-008-0492-7

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  63 in total

1.  Differential facilitation of N- and P/Q-type calcium channels during trains of action potential-like waveforms.

Authors:  Kevin P M Currie; Aaron P Fox
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

2.  P-type calcium channels blocked by the spider toxin omega-Aga-IVA.

Authors:  I M Mintz; V J Venema; K M Swiderek; T D Lee; B P Bean; M E Adams
Journal:  Nature       Date:  1992-02-27       Impact factor: 49.962

3.  An activity-dependent increased role for L-type calcium channels in exocytosis is regulated by adrenergic signaling in chromaffin cells.

Authors:  L Polo-Parada; S-A Chan; C Smith
Journal:  Neuroscience       Date:  2006-09-08       Impact factor: 3.590

4.  The blocking effects of omega-conotoxin on Ca current in bovine chromaffin cells.

Authors:  M Hans; P Illes; K Takeda
Journal:  Neurosci Lett       Date:  1990-06-22       Impact factor: 3.046

5.  Two distinct populations of calcium channels in a clonal line of pituitary cells.

Authors:  C M Armstrong; D R Matteson
Journal:  Science       Date:  1985-01-04       Impact factor: 47.728

6.  Opioid inhibition of Ca2+ channel subtypes in bovine chromaffin cells: selectivity of action and voltage-dependence.

Authors:  A Albillos; E Carbone; L Gandía; A G García; A Pollo
Journal:  Eur J Neurosci       Date:  1996-08       Impact factor: 3.386

7.  Distinctive biophysical and pharmacological properties of class A (BI) calcium channel alpha 1 subunits.

Authors:  W A Sather; T Tanabe; J F Zhang; Y Mori; M E Adams; R W Tsien
Journal:  Neuron       Date:  1993-08       Impact factor: 17.173

Review 8.  Distinctive pharmacology and kinetics of cloned neuronal Ca2+ channels and their possible counterparts in mammalian CNS neurons.

Authors:  J F Zhang; A D Randall; P T Ellinor; W A Horne; W A Sather; T Tanabe; T L Schwarz; R W Tsien
Journal:  Neuropharmacology       Date:  1993-11       Impact factor: 5.250

9.  Differential activation of adenosine receptors decreases N-type but potentiates P-type Ca2+ current in hippocampal CA3 neurons.

Authors:  D J Mogul; M E Adams; A P Fox
Journal:  Neuron       Date:  1993-02       Impact factor: 17.173

10.  Calcium channel subtypes in cat chromaffin cells.

Authors:  A Albillos; A R Artalejo; M G López; L Gandía; A G García; E Carbone
Journal:  J Physiol       Date:  1994-06-01       Impact factor: 5.182

View more
  6 in total

Review 1.  Roles of Na+, Ca2+, and K+ channels in the generation of repetitive firing and rhythmic bursting in adrenal chromaffin cells.

Authors:  Christopher J Lingle; Pedro L Martinez-Espinosa; Laura Guarina; Emilio Carbone
Journal:  Pflugers Arch       Date:  2017-08-03       Impact factor: 3.657

Review 2.  Human nicotinic receptors in chromaffin cells: characterization and pharmacology.

Authors:  Almudena Albillos; J Michael McIntosh
Journal:  Pflugers Arch       Date:  2017-10-20       Impact factor: 3.657

3.  Native α6β4* nicotinic receptors control exocytosis in human chromaffin cells of the adrenal gland.

Authors:  Alberto Pérez-Alvarez; Alicia Hernández-Vivanco; J Michael McIntosh; Almudena Albillos
Journal:  FASEB J       Date:  2011-09-14       Impact factor: 5.191

4.  Pharmacological characterization of native α7 nicotinic ACh receptors and their contribution to depolarization-elicited exocytosis in human chromaffin cells.

Authors:  Alberto Pérez-Alvarez; Alicia Hernández-Vivanco; Sergio Alonso Y Gregorio; Angel Tabernero; J Michael McIntosh; Almudena Albillos
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 5.  Past, present and future of human chromaffin cells: role in physiology and therapeutics.

Authors:  Alberto Pérez-Alvarez; Alicia Hernández-Vivanco; Almudena Albillos
Journal:  Cell Mol Neurobiol       Date:  2010-11-24       Impact factor: 5.046

6.  Expression of α3β2β4 nicotinic acetylcholine receptors by rat adrenal chromaffin cells determined using novel conopeptide antagonists.

Authors:  Arik J Hone; Lola Rueda-Ruzafa; Thomas J Gordon; Joanna Gajewiak; Sean Christensen; Tino Dyhring; Almudena Albillos; J Michael McIntosh
Journal:  J Neurochem       Date:  2020-02-11       Impact factor: 5.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.